198 related articles for article (PubMed ID: 37330108)
21. Gangliosides in the differentiation process of primary neurons: the specific role of GM1-oligosaccharide.
Di Biase E; Lunghi G; Fazzari M; Maggioni M; Pomè DY; Valsecchi M; Samarani M; Fato P; Ciampa MG; Prioni S; Mauri L; Sonnino S; Chiricozzi E
Glycoconj J; 2020 Jun; 37(3):329-343. PubMed ID: 32198666
[TBL] [Abstract][Full Text] [Related]
22. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.
Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA
J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553
[TBL] [Abstract][Full Text] [Related]
23. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
Olanow CW; Brundin P
Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
[TBL] [Abstract][Full Text] [Related]
24. Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans.
Wu G; Lu ZH; Kulkarni N; Ledeen RW
J Neurosci Res; 2012 Oct; 90(10):1997-2008. PubMed ID: 22714832
[TBL] [Abstract][Full Text] [Related]
25. Novel insights on GM1 and Parkinson's disease: A critical review.
Fazzari M; Di Biase E; Lunghi G; Mauri L; Chiricozzi E; Sonnino S
Glycoconj J; 2022 Feb; 39(1):27-38. PubMed ID: 35064857
[TBL] [Abstract][Full Text] [Related]
26. GM1 structural requirements to mediate neuronal functions.
Fazzari M; Lunghi G; Di Biase E; Maggioni M; Carsana EV; Cioccarelli L; Vigani L; Loberto N; Aureli M; Mauri L; Ciampa MG; Valsecchi M; Takato K; Imamura A; Ishida H; Ben Mariem O; Saporiti S; Palazzolo L; Chiricozzi E; Eberini I; Sonnino S
Glycoconj J; 2023 Dec; 40(6):655-668. PubMed ID: 38100017
[TBL] [Abstract][Full Text] [Related]
27. Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease.
Guo M; Wang J; Zhao Y; Feng Y; Han S; Dong Q; Cui M; Tieu K
Brain; 2020 May; 143(5):1476-1497. PubMed ID: 32355963
[TBL] [Abstract][Full Text] [Related]
28. Transient Lipid-Protein Structures and Selective Ganglioside Uptake During α-Synuclein-Lipid Co-aggregation.
Gaspar R; Idini I; Carlström G; Linse S; Sparr E
Front Cell Dev Biol; 2021; 9():622764. PubMed ID: 33681202
[TBL] [Abstract][Full Text] [Related]
29. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.
Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A
Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897
[TBL] [Abstract][Full Text] [Related]
30. Modulation of calcium signaling depends on the oligosaccharide of GM1 in Neuro2a mouse neuroblastoma cells.
Lunghi G; Fazzari M; Di Biase E; Mauri L; Sonnino S; Chiricozzi E
Glycoconj J; 2020 Dec; 37(6):713-727. PubMed ID: 33201378
[TBL] [Abstract][Full Text] [Related]
31. Structural and dynamic views of GM1 ganglioside.
Yagi-Utsumi M; Kato K
Glycoconj J; 2015 May; 32(3-4):105-12. PubMed ID: 25931034
[TBL] [Abstract][Full Text] [Related]
32. The oligosaccharide portion of ganglioside GM1 regulates mitochondrial function in neuroblastoma cells.
Fazzari M; Audano M; Lunghi G; Di Biase E; Loberto N; Mauri L; Mitro N; Sonnino S; Chiricozzi E
Glycoconj J; 2020 Jun; 37(3):293-306. PubMed ID: 32266604
[TBL] [Abstract][Full Text] [Related]
33. On the mechanism of internalization of alpha-synuclein into microglia: roles of ganglioside GM1 and lipid raft.
Park JY; Kim KS; Lee SB; Ryu JS; Chung KC; Choo YK; Jou I; Kim J; Park SM
J Neurochem; 2009 Jul; 110(1):400-11. PubMed ID: 19457104
[TBL] [Abstract][Full Text] [Related]
34. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease.
Van der Perren A; Macchi F; Toelen J; Carlon MS; Maris M; de Loor H; Kuypers DR; Gijsbers R; Van den Haute C; Debyser Z; Baekelandt V
Neurobiol Aging; 2015 Mar; 36(3):1559-68. PubMed ID: 25660193
[TBL] [Abstract][Full Text] [Related]
35. Deciphering the glycolipid code of Alzheimer's and Parkinson's amyloid proteins allowed the creation of a universal ganglioside-binding peptide.
Yahi N; Fantini J
PLoS One; 2014; 9(8):e104751. PubMed ID: 25140899
[TBL] [Abstract][Full Text] [Related]
36. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
[TBL] [Abstract][Full Text] [Related]
37. Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinson's disease.
van Rooijen BD; Claessens MM; Subramaniam V
Curr Protein Pept Sci; 2010 Aug; 11(5):334-42. PubMed ID: 20423294
[TBL] [Abstract][Full Text] [Related]
38. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
39. Targeting α-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease.
Haque ME; Akther M; Azam S; Kim IS; Lin Y; Lee YH; Choi DK
Br J Pharmacol; 2022 Jan; 179(1):23-45. PubMed ID: 34528272
[TBL] [Abstract][Full Text] [Related]
40. Oligosaccharide portion of GM1 enhances process formation by S20Y neuroblastoma cells.
Schengrund CL; Prouty C
J Neurochem; 1988 Jul; 51(1):277-82. PubMed ID: 3379408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
